Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 811 to 820 of 2004

TitleReference numberPublishedLast updated
Darolutamide with androgen deprivation therapy for treating hormone-relapsed non-metastatic prostate cancerTA660
Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinomaTA661
Durvalumab in combination for untreated extensive-stage small-cell lung cancer (terminated appraisal)TA662
Swallowable gastric balloon capsule for weight lossIPG684
Acute coronary syndromesNG185
Drug-eluting stents for the treatment of coronary artery diseaseTA152
Galcanezumab for preventing migraineTA659
Guidance on the use of coronary artery stentsTA71
Siponimod for treating secondary progressive multiple sclerosisTA656
Carfilzomib for previously treated multiple myelomaTA657

Results per page

  1. 10
  2. 25
  3. 50
  4. All